Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Air Force Nuclear Weapons Center Pandemic Case Management Suite RFI

by Global Biodefense Staff
September 1, 2021

Wearables such as watches and rings are being tested in the DoD to detect biometric indicators such as respiratory rate, body temperature, sleep data, heart rate data, and pulse oximetry (blood oxygen) level changes for early indicators of illness. Image credit: Cynthia Griggs

The U.S. Air Force Nuclear Weapons Center is looking for information on wearable devices and biometric data systems to support health monitoring and contact tracing activities in conjunction with the Pandemic Case Management Suite (PCMS).

PCMS has been identified as an operational requirement in an effort to support the USAF’s fight against the COVID-19 and future biological outbreaks by providing early infection identification and digital traceability of infected personnel to commanders to inform personnel and unit readiness decisions. 

Information is sought on technologies that can provide insight into biometric data (ex: heart rate fluctuation, O2 levels, heart rate, heart rate variability, temperature, inter-beat interval, etc.) that can identify a potential infection early and alert the user through its user dashboard.

The wearable technology needs to have an ability to integrate into a third-party dashboard and be able to comply with and obtain a cybersecurity authorization.

The Government is also seeking information on the commercial availability of data integration services which will require the integration of dozens of commercial data streams. An interested party would have ample security capabilities to protect user data and personally identifiable information (PII).

  • Is the technology approved for use in secure environments?
  • How are supply-chain risks mitigated?
  • Are there foreign companies in your supply chain?
  • How is user privacy protected?
  • Is private industry using your technology or service for COVID-19 today?
  • What has been the user adoption rate when used for COVID-19?
  • What impact has technology or service had on the organizations return-to-normal business operations?
  • Has the number of active users declined since the vaccines have been released?
  • Has your device shown a correlation between collected biometric data and COVID-19 infection (and/or symptom onset)?
  • Have these results been analyzed and/or confirmed in a peer review setting?
  • Would your company be willing to sign an Associated Contractor Agreement (ACA) to ensure the free flow of non-proprietary information to enhance success of the PCMS program?

Additional requirements are detailed at SAM.gov (PCMS_SEPT2021).

RELATED:

Palantir Awarded PCMS Data Integration Purchase Order From USAF Nuclear Weapons Center

AFWERX Pandemic Case Management Suite – COVID 19 Tracing Wearables RFI

Tags: COVID-19Editor PickInnovationOpportunitiesRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy